Millendo Therapeutics' Debt Round

Millendo Therapeutics raised a round of funding on April 23, 2012. Investors include Frazier Healthcare.

Millendo Therapeutics, previously known as Atterocor, is a drug development company focused on a novel treatment for adrenal cancer. The company is accelerating the development of a new adrenal-target…

Articles about Millendo Therapeutics' Debt Round: